Merck & Co., Inc. Noncontrolling Interest, Amount Represented by Preferred Stock
Merck & Co., Inc. (MRK) had Noncontrolling Interest, Amount Represented by Preferred Stock of $2.40 billion as of 2013-12-31, per its 10-K filed 2014-02-27.
Discontinued › Notes › Noncontrolling Interest
us-gaap:MinorityInterestAmountRepresentedByPreferredStock · last filed 2014-05-08
- 2013-12-31: Noncontrolling Interest, Amount Represented by Preferred Stock $2.40B.
- 2013-03-31: Noncontrolling Interest, Amount Represented by Preferred Stock $2.40B.
- 2012-12-31: Noncontrolling Interest, Amount Represented by Preferred Stock $2.40B.
- 2012-09-30: Noncontrolling Interest, Amount Represented by Preferred Stock $2.40B.
| Period end | Noncontrolling Interest, Amount Represented by Preferred Stock |
|---|---|
| 2013-12-31 | $2.40B 10-K · filed 2014-02-27 |
| 2013-03-31 | $2.40B 10-Q · filed 2013-05-09 |
| 2012-12-31 | $2.40B 10-K · filed 2013-02-28 |
| 2012-09-30 | $2.40B 10-Q · filed 2012-11-09 |
| 2012-06-30 | $2.40B 10-Q · filed 2012-08-07 |
| 2012-03-31 | $2.40B 10-Q · filed 2012-05-08 |
| 2011-12-31 | $2.40B 10-K · filed 2012-02-28 |
| 2011-09-30 | $2.40B 10-Q · filed 2011-11-08 |
| 2011-06-30 | $2.40B 10-Q · filed 2011-08-08 |
| 2011-03-31 | $2.40B 10-Q · filed 2011-05-09 |
| 2010-12-31 | $2.40B 10-K · filed 2012-02-28 |
| 2010-09-30 | $2.40B 10-Q · filed 2010-11-08 |
| 1998-12-31 | $2.40B 10-Q · filed 2014-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |